{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Ben+Bradley&uin=193605", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?tablingMemberPrinted.=Ben+Bradley&uin=193605", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Ben+Bradley&uin=193605&_metadata=all", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Ben+Bradley&_page=0&uin=193605", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Ben+Bradley&uin=193605", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Ben+Bradley&uin=193605", "items" : [{"_about" : "http://data.parliament.uk/resources/1010780", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1010780/answer", "answerText" : {"_value" : "
The current new-born screening programme in the United Kingdom screens for nine rare but serious conditions including phenylketonuria (PKU). To recognise rare conditions such as PKU, doctors and other healthcare professionals are expected to ensure their clinical knowledge remains up-to-date and to identify their ongoing learning needs as part of their continuing professional development. This activity should include taking account of new research and developments in guidance in relevant specialty areas, such as those produced by the National Institute for Health and Care Excellence or the Royal Colleges, to ensure that they can continue to provide high quality care to all patients.<\/p>
<\/p>
Steps to increase the awareness of rare diseases such as PKU are being taken through the implementation of the UK Strategy for Rare Diseases. The Strategy includes commitments to improving the lives of all patients affected by rare diseases including in areas of identification/ prevention and diagnosis and early intervention. The Government is committed to implementing the Strategy\u2019s commitments and in January 2018, the Department and NHS England published Implementation Plans setting out their actions for England.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2018-11-28", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-11-28T17:39:49.97Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-11-20", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Phenylketonuria"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help raise awareness of Phenylketonuria.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4663", "label" : {"_value" : "Biography information for Ben Bradley"} } , "tablingMemberConstituency" : {"_value" : "Mansfield"} , "tablingMemberPrinted" : [{"_value" : "Ben Bradley"} ], "uin" : "193605"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 1, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }